---
title: "Gilead Sciences (GILD) Gets a Hold from Goldman Sachs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293389873.md"
description: "Goldman Sachs analyst Salveen Richter maintained a Hold rating on Gilead Sciences (GILD) with a $130 price target. This follows Leerink Partners' downgrade to Hold with a $127 target. Despite these individual analyst actions, the broader market consensus remains a Strong Buy with an average price target of $159.10, implying significant upside potential."
datetime: "2026-07-21T21:43:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293389873.md)
  - [en](https://longbridge.com/en/news/293389873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293389873.md)
---

# Gilead Sciences (GILD) Gets a Hold from Goldman Sachs

In a report released yesterday, Salveen Richter from Goldman Sachs maintained a Hold rating on Gilead Sciences, with a price target of $130.00. The company’s shares closed today at $133.21.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Richter covers the Healthcare sector, focusing on stocks such as Regeneron, Moderna, and Relay Therapeutics. According to TipRanks, Richter has an average return of 11.4% and a 48.36% success rate on recommended stocks.

Currently, the analyst consensus on Gilead Sciences is a Strong Buy with an average price target of $159.10, a 19.44% upside from current levels. In a report released yesterday, Leerink Partners also downgraded the stock to a Hold with a $127.00 price target.

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [RLAY.US](https://longbridge.com/en/quote/RLAY.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Florida Financial Advisors LLC Decreases Stock Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/293449499.md)
- [Gilead posts press release on once-weekly oral HIV regimen trial results](https://longbridge.com/en/news/293353498.md)
- [Dai ichi Life Insurance Company Ltd Sells 13,858 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/293816705.md)
- [CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L) 1-Positive First-Line Metastatic Triple-Negative Breast Cancer | GILD Stock News](https://longbridge.com/en/news/293740895.md)
- [Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today](https://longbridge.com/en/news/293268846.md)